GLP-1 (glucagon-like peptide-1) is a hormone that helps regulate appetite, blood sugar, and digestion. GLP-1 medications like semaglutide and tirzepatide mimic this natural hormone to reduce hunger, slow gastric emptying, and improve insulin sensitivity — leading to steady, effective weight loss.

We use clinically proven GLP-1 medications, including Semaglutide and Tirzepatide, depending on your individual medical history, goals, and tolerance.

Most patients lose 10–20% of their body weight over several months, depending on dose, consistency, and lifestyle habits. Results vary, but GLP-1 medications have some of the highest clinical success rates.

Many patients begin noticing reduced hunger within the first 1–2 weeks. Visible weight loss often begins after 3–6 weeks, with steady progress as dosing is gradually increased.

GLP-1 medications are FDA-approved and widely used. The most common side effects are nausea, bloating, constipation, or mild GI discomfort, which typically improve with slow dose increases. You’ll be medically monitored throughout treatment.

GLP-1 helps naturally reduce cravings and appetite, but combining medication with healthy nutrition, sleep, and movement leads to the best long-term results. We provide guidance tailored to your needs.

Ideal candidates include adults struggling with weight loss due to metabolic resistance, PCOS, insulin resistance, perimenopause, or prior weight-loss plateaus. A medical evaluation ensures safety and fit.